Iodine-125 interstitial brachytherapy for malignant lacrimal sac tumours: an innovative technique
Author:
Funder
National Natural Science Foundation of China
Natural Science Foundation of Shaanxi Province
Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology
Link
http://www.nature.com/articles/s41433-020-1098-3.pdf
Reference29 articles.
1. Krishna Y, Coupland SE. Lacrimal sac tumors—a review. Asia Pac J Ophthalmol. 2017;6:173–8.
2. Parmar DN, Rose GE. Management of lacrimal sac tumours. Eye. 2003;17:599–606.
3. Shields JA, Shields CL, Freire JE, Brady LW, Komarnicky L. Plaque radiotherapy for selected orbital malignancies: preliminary observations: the 2002 Montgomery Lecture, part 2. Ophthalmic Plast Reconstr Surg. 2003;19:91–5.
4. Klufas MA, Wolden SL, Bohle GC, Wexler LH, Abramson DH. Exenteration and custom implant brachytherapy as a treatment for recurrent primary extraskeletal orbital ewing sarcoma. Ophthalmic Plast Reconstr Surg. 2015;31:e89–91.
5. Moore RF. Choroidal sarcoma treated by the intraocular insertion of radon seeds. Br J Ophthalmol. 1930;14:145–52.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effectiveness of Nasolacrimal SCC Treatments and Promising Role of Chemo‐Induction: A Case Report and Systematic Review;The Laryngoscope;2024-04-23
2. Personalized treatment for patients with lacrimal sac squamous cell carcinoma;Canadian Journal of Ophthalmology;2024-04
3. Stent loaded with radioactive Iodine-125 seeds for adenoid cystic carcinoma of central airway: A case report of innovative brachytherapy;Frontiers in Oncology;2023-03-28
4. Surgical resection and orbital iodine-125 brachytherapy for orbital malignancy: a novel treatment for orbital lymphoma;International Ophthalmology;2023-03-12
5. A retrospective study on unresectable or inoperable head and neck cancers treated with stereotactic ablative brachytherapy;Journal of Contemporary Brachytherapy;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3